No Prescription |
 |
 | ||
|
Cimetidine Tagamet |
|
| ||
No Prescription » Prescription Drugs 4 » Cimetidine Tagamet Cimetidine is used to treat ulcers of the stomach and intestines and prevent them from coming back after they have healed. This medication is also used to treat certain stomach and throat (esophagus) problems caused by too much stomach acid (e.g. Zollinger-Ellison syndrome erosive esophagitis) or a backward flow of stomach acid into the esophagus (acid reflux disease/GERD). Decreasing extra stomach acid can help relieve symptoms such as stomach pain heartburn difficulty swallowing persistent cough and trouble sleeping. It can also prevent serious acid damage to your digestive system (e.g. ulcers cancer of the esophagus).Cimetidine belongs to a class of drugs commonly called H2 blockers. It works by reducing the amount of acid in your stomach.This medication is also available without a prescription. It is used to treat occasional heartburn caused by too much acid in the stomach (also called acid indigestion or sour stomach). It is also used to prevent heartburn and acid indigestion caused by certain foods and beverages. If you are taking this medication for self-treatment it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. (See also Precautions.)How to use Cimetidine OralTake this medication by mouth with or without food as directed by your doctor.The dosage and length of treatment are based on your medical condition and response to therapy. Follow your doctor's instructions carefully. If you are also taking antacids to relieve stomach pain as recommended by your doctor separate them from this medication by at least 1 hour.Take this medication regularly as prescribed in order to get the most benefit from it. To help you remember take it at the same time(s) each day. Do not increase your dose or take it more often than directed. Continue to take this medication for the prescribed length of treatment even if you are feeling better. Stopping treatment too early may delay the healing process.If you are using nonprescription cimetidine for self-treatment of acid indigestion or heartburn take 1 tablet by mouth with a glass of water as needed. To prevent heartburn take 1 tablet by mouth with a glass of water right before or up to 30 minutes before eating food or drinking beverages that cause heartburn. Do not take more than 2 tablets in 24 hours unless directed by your doctor. Do not take for more than 14 days in a row without talking with your doctor.Inform your doctor if your symptoms do not improve or if they worsen. Buy Cimetidine Tagamet and other Prescription Drugs 4 products online at Medstore. Buy Online at Medstore - Click Here!
About Cimetidine Tagamet: Product Type: Prescription Drugs 4 Cimetidine ( Tagamet Generic Cimetidine ) Cimetidine (Tagamet Generic Cimetidine) Tagamet Generic Cimetidine 200mg 100 tabs 400mg 800mg Tagamet Generic Cimetidine Cimetidine
View more Prescription Drugs 4 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
